VAERS Explorer
Back to explore

Report #2864405

Received Oct 8, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Unknown
Age
Age unknown
State
CO
Recovered
Unknown
Vaccinated
Sep 25, 2023
Onset
Sep 25, 2023
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSUNK——

Symptoms (1)

Expired product administered

Symptom narrative

Boostrix - Expired dose; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received DTPa (Reduced antigen) (Boostrix) (expiry date 24-SEP-2023) for prophylaxis. On 25-SEP-2023, the patient received Boostrix. On 25-SEP-2023, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: Boostrix - Expired dose). The outcome of the expired vaccine used was not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 29-SEP-2025 The patient received Boostrix vaccine, which was expired, which led to expired vaccine used. The vaccine remained in stable temperature per manufacturer recommendations until administration. The reporter asked was this still a viable administration.